Eisai Co., Ltd. (ESALF)
OTCMKTS
· Delayed Price · Currency is USD
27.50
-1.81 (-6.18%)
Jun 25, 2025, 8:00 PM EDT
Eisai Employees
Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.
Employees
10,917
Change (1Y)
-150
Growth (1Y)
-1.36%
Revenue / Employee
$482,873
Profits / Employee
$28,402
Market Cap
7.96B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
Eisai News
- 21 days ago - Eisai: Leqembi Approved In EU (Rating Downgrade) - Seeking Alpha
- 6 weeks ago - Eisai Co., Ltd. (ESALF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Eisai Co., Ltd. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 weeks ago - Eisai GAAP EPS of ¥163.76, revenue of ¥789.4B; initiates FY outlook - Seeking Alpha
- 2 months ago - Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion - Benzinga
- 2 months ago - Biogen/ Eisai win EU approval for Alzheimer’s therapy - Seeking Alpha
- 2 months ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 3 months ago - Japanese Stocks Rise With Market Focused on U.S. Trade News - Barron's